Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Tyra Biosciences, Inc. | Director | Common Stock | 89.6K | $1.79M | $20.00 | Jun 13, 2024 | Direct |
Avalo Therapeutics, Inc. | Director | Restricted Stock Units | 9.5K | $4.93K | $0.52 | Aug 13, 2024 | Direct |
Avalo Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 24.6K | Aug 13, 2024 | Direct | ||
Tyra Biosciences, Inc. | Director | Stock Option (Right to Buy) | 0 | Jun 13, 2024 | Direct |